Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition

Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition

ObjectiveThis article investigates the role of Transgelin (TAGLN) in the epithelial–mesenchymal transition (EMT) of esophageal squamous cell carcinomas (ESCC) and its possible mechanism of inhibiting the invasion of these cancers.MethodsTissue specimens and clinical information of patients with ESCC...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Boli Yang, Qiuyu Chen, Changshan Wan, Siyuan Sun, Lanping Zhu, Zhizhong Zhao, Weilong Zhong, Bangmao Wang
Natura:	Articolo
Lingua:	English
Pubblicazione:	Frontiers Media S.A. 2021-08-01
Serie:	Frontiers in Oncology
Soggetti:	esophageal squamous cell carcinoma (ESCC) transgelin epithelial mesenchymal transition (EMT) invasion metastasis proliferation
Accesso online:	https://www.frontiersin.org/articles/10.3389/fonc.2021.709486/full

Documenti analoghi

Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
di: Boli Yang, et al.
Pubblicazione: (2022-03-01)

BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial–mesenchymal transition and angiogenesis
di: Yan Zhao, et al.
Pubblicazione: (2021-05-01)

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
di: Zongdan Jiang, et al.
Pubblicazione: (2021-11-01)

Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer
di: Yan Sun, et al.
Pubblicazione: (2018-07-01)

Serum transgelin is a novel prognostic biomarker for COVID-19 patients
di: Lei Gao, et al.
Pubblicazione: (2024-11-01)

Microarray Analysis of Radioresistance-associated Genes in Esophageal Squamous Cell Carcinoma
di: ZHU Qingshan, et al.
Pubblicazione: (2019-03-01)

Evolution and function of calponin and transgelin
di: Tzu-Bou Hsieh, et al.
Pubblicazione: (2023-06-01)

Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
di: Mingyue Wang, et al.
Pubblicazione: (2019-10-01)

Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?
di: Karolina Woziwodzka, et al.
Pubblicazione: (2021-12-01)

Case Report: Esophageal squamous cell carcinoma in a 13-year-old boy with a history of esophageal atresia with tracheoesophageal fistula
di: B. Bernar, et al.
Pubblicazione: (2024-10-01)

Involvement of TGFBI-TAGLN axis in cancer stem cell property of head and neck squamous cell carcinoma
di: Motoharu Sarubo, et al.
Pubblicazione: (2024-03-01)

Cyclosporine A Protects Podocytes by Regulating Transgelin in Adriamycin-Induced Podocyte Injury
di: Xiaoyan Li, et al.
Pubblicazione: (2024-07-01)

Occupational risks of esophageal cancer in Taiwanese men
di: Shih-Hui Huang, et al.
Pubblicazione: (2012-12-01)

Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment
di: Pavla Bouchalova, et al.
Pubblicazione: (2021-09-01)

miR‐130a‐3p regulated TGF‐β1‐induced epithelial‐mesenchymal transition depends on SMAD4 in EC‐1 cells
di: Xiaokang Tian, et al.
Pubblicazione: (2019-03-01)

Clinical value of station 4R node dissection in esophageal squamous cell carcinoma
di: Xin-ye Wang, et al.
Pubblicazione: (2023-12-01)

The role of AGAP2-AS1, DLEU2, HMBOX1_1, and UGDH-AS1 in the progression of esophageal squamous cell carcinoma
di: Samaneh Talebi, et al.
Pubblicazione: (2024-10-01)

Current advances and future perspectives on the functional roles and clinical implications of circular RNAs in esophageal squamous cell carcinoma: more influential than expected
di: Chenxi Ju, et al.
Pubblicazione: (2022-06-01)

NUAK1 promotes tumor metastasis through upregulating slug transcription in esophageal squamous cell carcinoma
di: Huiru Yang, et al.
Pubblicazione: (2023-11-01)

Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration
di: Jiefei Xiao, et al.
Pubblicazione: (2018-10-01)

Elucidating the role of CYFIP2 in conferring cisplatin resistance in esophageal squamous cell carcinoma
di: Peipei Zhang, et al.
Pubblicazione: (2024-11-01)

Natural alkaloids as potential treatments for esophageal squamous-cell carcinoma: A comprehensive review
di: Eugene Jamot Ndebia, et al.
Pubblicazione: (2024-07-01)

Drug repositioning for esophageal squamous cell carcinoma
di: Adam N. Bennett, et al.
Pubblicazione: (2022-09-01)

Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
di: Pei-Wen Yang, et al.
Pubblicazione: (2019-11-01)

Global research trend of esophageal squamous cell carcinoma from 2012 to 2022: a bibliometric analysis
di: Zehua Zhang, et al.
Pubblicazione: (2022-08-01)

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
di: Zhang Q, et al.
Pubblicazione: (2019-08-01)

lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma
di: Shujun Zhang, et al.
Pubblicazione: (2021-05-01)

Plasma-metabolite-based machine learning is a promising diagnostic approach for esophageal squamous cell carcinoma investigation
di: Zhongjian Chen, et al.
Pubblicazione: (2021-08-01)

Development and Validation of a Ferroptosis-Related Gene Signature and Nomogram for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma
di: Jiecheng Ye, et al.
Pubblicazione: (2021-10-01)

Transgelins: Cytoskeletal Associated Proteins Implicated in the Metastasis of Colorectal Cancer
di: Jingwen Liu, et al.
Pubblicazione: (2020-10-01)

AKAP12 inhibits esophageal squamous carcinoma cell proliferation, migration, and cell cycle via the PI3K/AKT signaling pathway
di: Xingyi Li, et al.
Pubblicazione: (2023-12-01)

Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer
di: Zhe Zhang, et al.
Pubblicazione: (2023-04-01)

Capn4 promotes esophageal squamous cell carcinoma metastasis by regulating ZEB1 through the Wnt/β‐catenin signaling pathway
di: Yun‐Long Zhao, et al.
Pubblicazione: (2019-01-01)

SATB2 promotes radiation resistance of esophageal squamous cell carcinoma by regulating epithelial-to-mesenchymal transition via the Wnt/β-catenin pathway
di: Chen Lin, et al.
Pubblicazione: (2025-02-01)

The Effects of a Transgelin-2 Agonist Administered at Different Times in a Mouse Model of Airway Hyperresponsiveness
di: Hong-Kai Yuan, et al.
Pubblicazione: (2022-06-01)

3,3′-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE2 pathway
di: Peiyao Zhu, et al.
Pubblicazione: (2020-06-01)

Predictive Value of LINC01133 for Unfavorable Prognosis was Impacted by Alcohol in Esophageal Squamous Cell Carcinoma
di: Xian-Zi Yang, et al.
Pubblicazione: (2018-07-01)

AURKA knockdown inhibits esophageal squamous cell carcinoma progression through ferroptosis
di: Yuan Mi, et al.
Pubblicazione: (2024-04-01)

Identifying LATS2 as a prognostic biomarker relevant to immune infiltrates in human esophageal squamous cell carcinoma
di: Minqi Zhu, et al.
Pubblicazione: (2022-09-01)

Overexpression of Phosphoserine Aminotransferase 1 (PSAT1) Predicts Poor Prognosis and Associates with Tumor Progression in Human Esophageal Squamous Cell Carcinoma
di: Bingyan Liu, et al.
Pubblicazione: (2016-07-01)